Latest News Archive

Please select Category, Year, and then Month to display items

Department of Architecture celebrates international recognition

22 December 2023 | Story Leonie Bolleurs | Photo Supplied

3D-Printed Sculptural Artefact — The 3D-printed sculptural artefact entered by a group of third-years from the UFS.

A group of third-year students from the UFS Department of Architecture exhibited their work at the 2023 Venice Biennale, an international architecture exhibition showcasing ground-breaking architectural work from various countries around the world.

The contributions of world-class architects, researchers, and institutions in architecture are exhibited at this exhibition. “To be featured in this exhibition means that we are recognised by the international community as one of the leading architectural learning sites in South Africa and the work being produced at the institution deserves international acclaim,” says Phadi Mabe, Lecturer in the department.

The students representing the university with Mabe and participating in this event are Anya Strydom, Yamkelwa Simelane, Jan Truter, and Khalipha Radebe.

Mabe says the artefact produced from this project is a 3D-printed sculptural device that shows the translation between sound and object and illustrates the sound data through 3D-printed forms. “The sound structures of South Africa’s languages are mapped three-dimensionally to create a visual and spatial record of language. This unique artefact demonstrates that there are uncharted terrains in architecture, suggesting alternative dimensions that can be extrapolated to show that architecture can represent the intangible” he explains.

The UFS artefact was one of six design artefacts selected for the 18th International Architecture Exhibition – La Biennale di Venezia, which opened to the public in May and closes on 26 November 2023.

Hosted by the Department of Sport, Arts and Culture, the competition involved an emphasis on students incorporating African traditional architecture into their design models.

News Archive

New research informs improved treatment of brain inflammation

2017-10-13

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish

Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept